Talk:Broad Institute

From Wikipedia, the free encyclopedia

This article is misleading. The Broad institute was created in 2004 by the *merger* of the Whitehead Institute's Center for Genome Research (directed by Eric Lander) and The Institute for Chemistry and Cell Biology (ICCB), which was located at Harvard Medical School. The ICCB was founded in 1997 by Tim Mitchison (now at Harvard Medical School's department of Systems Biology), and Stuart Schreiber, Howard Hughes Investigator and Professor of Chemistry at Harvard University. Stuart Schreiber now directs the Broad Chemical Biology program, which is one of 4 general research organizations within the institute. While the CGR component of the Broad Institute (now known as the Cell Circuits Program) is significant, and genome sequencing and analysis is a large-scale activity, the Broad Institute is comprised of a much wider array of research activities than the former CGR. The merger of the ICCB, CGR, and the laboratories of Todd Golub (Dana Farber Cancer Institute) and David Altshuler (Harvard Medical School, Mass. General Hospital), who are now directors of Cancer and Medical/Population Genetics programs, respectively, added significant breadth to the Broad's research profile to include everything from clinical medicine to synthetic chemistry and nearly every other relevant aspect of biomedical research under one roof.

In sum, to say that "The Broad Institute was founded as WICGR in 1990, and re-launched in 2004" overlooks the many research components that contribute to the success of the Broad Institute.